The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Rishu Gupta; Maya Debbaneh; Daniel Butler; Monica Huynh; Ethan Levin; Argentina Leon; John Koo; Wilson Liao

doi:10.3791/50509

Journal

/

Medicine

/

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

JoVE Journal
Medicine

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Medicine

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

38,697 Views

•

11:39 min

•

July 11, 2013

DOI:

10.3791/50509-v

DOI:

10.3791/50509-v

•

11:39 min

July 11, 2013

•

16 Views

Rishu Gupta^1,2, Maya Debbaneh^2,3, Daniel Butler^2,4, Monica Huynh^2,5, Ethan Levin², Argentina Leon², John Koo², Wilson Liao²

¹Keck School of Medicine,University of Southern California, ²Psoriasis and Skin Treatment Center Dermatology,University of California, San Francisco , ³University of California Irvine School of Medicine, ⁴University of Arizona College of Medicine, ⁵Chicago College of Osteopathic Medicine

Summary

Psoriasis is a chronic, immune-mediated inflammatory skin disease. The Goeckerman regimen, formulated for the treatment of psoriasis, consists of exposure to ultraviolet B (UVB) light and application of crude coal tar (CCT). The following protocol is for the administration of Goeckerman therapy for the treatment of moderate-to-severe psoriasis.